Chemoinformaics analysis of DI-O-METHYLAMENTOFLAVONE
| Molecular Weight | 566.518 | nRot | 5 |
| Heavy Atom Molecular Weight | 544.342 | nRig | 36 |
| Exact Molecular Weight | 566.121 | nRing | 6 |
| Solubility: LogS | -4.618 | nHRing | 2 |
| Solubility: LogP | 6.237 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 6 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 4 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 32 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 34 |
| nHA | 10 | APOL | 76.1294 |
| nHD | 4 | BPOL | 30.7506 |
| QED | 0.203 |
| Synth | 2.98 |
| Natural Product Likeliness | 1.093 |
| NR-PPAR-gamma | 0.982 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.273 |
| Pgp-sub | 0.173 |
| HIA | 0.301 |
| CACO-2 | -5.078 |
| MDCK | 0.000014 |
| BBB | 0.001 |
| PPB | 0.927835 |
| VDSS | 0.5 |
| FU | 0.0752589 |
| CYP1A2-inh | 0.759 |
| CYP1A2-sub | 0.692 |
| CYP2c19-inh | 0.797 |
| CYP2c19-sub | 0.045 |
| CYP2c9-inh | 0.621 |
| CYP2c9-sub | 0.945 |
| CYP2d6-inh | 0.06 |
| CYP2d6-sub | 0.91 |
| CYP3a4-inh | 0.218 |
| CYP3a4-sub | 0.11 |
| CL | 4.14 |
| T12 | 0.197 |
| hERG | 0.045 |
| Ames | 0.28 |
| ROA | 0.054 |
| SkinSen | 0.64 |
| Carcinogencity | 0.036 |
| EI | 0.816 |
| Respiratory | 0.081 |
| NR-Aromatase | 0.962 |
| Antiviral | Yes |
| Prediction | 0.768548 |